We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH Regulatory Science Improving, But Metrics Still Elusive: Shuren
CDRH Regulatory Science Improving, But Metrics Still Elusive: Shuren
A year-long effort to refine CDRH’s research mission and get more bang for the buck is showing positive results, but one goal — using metrics to track success — remains elusive, Director Jeffrey Shuren told a gathering of the FDA’s Science Board.